 Good morning. How's everybody doing today? Hope you're all having a great day. Hope everyone's having a great day and welcome to the Rich TV Live broadcast where we are going to talk to you today about the next super hyper growth stock that I think has enormous potential and enormous upside. And this is a company that I brought to you guys first. It's been a huge success story. Obviously, we've been talking about new me wellness for quite some time and you can actually see all the videos on YouTube. You can see that we made a video about new me wellness when it was at around 78 cents on YouTube. You can see currently now at a dollar 51. Here's the video right here. Here's the date on December 5, 2020, made a video on new me wellness when it was currently 78 cents. Today new me wellness resides at $1.51. I believe that the upside for them is absolutely tremendous and I want to tell you why. So we're going to go through why this morning. So you can see here it's been as low as 22 cents, been as high as 245. So you can see been as high as 245. So tremendous upside potential for new me wellness currently sitting at $1.51. So you see a stock go from 22 cents all the way up to 245. That's a 10 bagger, meaning it had a thousand percent return. Then it retraced a little bit, which is what almost all stocks do retraced to where it is today at $1.50, but still up tremendously from when I brought it to you first at 78 cents up around a hundred percent. That is the Canadian symbol for new me wellness, the U.S. symbol K Y S F currently at $1.21. You can see that these guys started at 15 cents and went as high as $1.90. Very, very interesting psychedelic play went from 15 cents to $1.90 and currently resides at $1.21. So I think that the upside is tremendous from here. And I think that as an investor, you're just looking for a dip. You're looking for an opportunity. You're looking for some panic. You're looking for some fear. You're looking for a red day to position yourself. I think the upside for these guys is tremendous. Like I said in my video on December 5th, when I thought that they would go well over a dollar and they have congratulations to investors on new me wellness. And I believe that this story is just starting to take hold. You can see her on bar chart. If you scroll down, they're up 19 percent in the last month and 115 percent in the last three months. I want to look at their key data right now with 247 million market cap, 163 million shares listed issued in outstanding. So not as tight of a float as we've seen with some of our other picks, but still a relatively tight float. And this is a company that's already raised millions of dollars. So they're very well capitalized. And we'll be watching to see if there's any news this morning as the market opens up. They did recently have some news. Here's the big news that they recently had yesterday. Optomy health and numinous wellness to conduct psychedelic lab research and development. Optomy health corp OPTI developers of a vertically integrated functional mushroom brand focused on the health and wellness sector is pleased to announce that effective January for 2021. It entered into a lab services agreement with numinous wellness. Recognize as an early leader into developing and supporting the safe evidence based accessible use of psychedelic assisted psychotherapies. Pap, numinous is aiding Optomy's mission to further the research and development of Canadian grown psilocybin producing mushrooms and related product formulations. So this is some big news for new me and I want to go through some more stuff here. So this is their investor deck. Numinous.ca investors. You can go to their website. An integrated ecosystem for healing at scale. Let's talk about some of the key points here. Numinous is an integrated mental health delivery company creating an ecosystem of health solutions to research develop and deliver safe evidence based accessible psychedelic assisted psychotherapy. Numinous bioscience is a health Canada licensed lab for psychedelic substance research developing IP while offering analytics services for revenue generation. Numinous R and D is developing psychedelic assisted therapeutics protocols to embrace. That's right. That's right. They are constantly doing everything to embrace and embed in mainstream health care led by medical leadership with global research and policy reform experience. Numinous health supports practitioners and developing best in class treatments by offering centralized numinous owned training facilities and other operational resources for effective care delivery and health care impact. This trifecta of solutions positions numinous at the forefront of psychedelics for healing and wellness. I'm a huge fan of numinous wellness. Obviously they've been a huge success already for our community and they're doing extremely well ever since we did this first video on YouTube and I believe that this is a story that's just getting started. They also have a first mover licensing advantage for psychedelic research. Obviously that is huge. Having first mover advantage is always a game changer and I was one of the first ones ever to talk to you guys about cannabis stocks. Now psychedelic stocks remind me of cannabis stocks. It is the new sector that everybody's getting excited about because it is literally changing the world. Now let's talk a little bit about why and what makes them so special. So psychedelics are living up to the hype as a mental health therapy. Numinous wellness Inc, NUMI in Canada, LKYSF in America is at the forefront of psychedelic medicine as institutional and retail investors start to pile in. Daniel Carbaum-Carsillo is a two-time Stanley Cup winner, one of the most recognizable enforcers in the National Hockey League and suffering from the aftermath of traumatic brain injury. This is why I would never ever ever have my son or my daughter playing sports where they could take shots to the head and obviously hockey, very physical sport and you know so is football and there's a lot of sports that are causing a lot of mental health issues and that's why I believe psychedelics are here to stay and they're going to be the future of mental health. Too many blows to the head will do that as an enforcer. His role was to protect star players at any cost and that literally was at the cost of his own health unfortunately. Really sad but luckily now in 2021 and beyond we've got psychedelics to help people that are in need. We've got psychedelics to help people that need the most help. People that are struggling mentally, physically with mental illness we've got a solution for them now. If you guys like these videos please smash the like button, comment down below, share the video everywhere and subscribe. If you have not joined the club you can join the trading club at, you can join the trading club at richpicksdaily.com. Any updates on UPI coming up? You know what? Not today but anything is possible at any time. Amjad, good morning, good morning Robert. Good morning young killer. If you guys like the video please smash the like button, comment down below, share the video everywhere and subscribe. Remember, RichTVLive is strictly for education and entertainment purposes. Always do your due diligence, always do your research before you invest in anything that we talk about here in RichTVLive. Always invest in the best, the best is blessed and you deserve the best. Here at RichTVLive we take a lot of pride in bringing you guys the best companies, early stage what we call rockets, undervalued, under-appreciated, under-exposed opportunities and new me wellness has been one of those. Now here's another article here, psychedelics are living up to the hype as a mental health therapy. Numinous wellness Inc, NUMI in Canada, LKYSF in America is at the forefront of psychedelic medicines as institutional and retail investors start to pile in. Now if you're trying to get into this sector, it's early. It's super early. So if you know it's early then it's really just kind of like a matter of time. It's just a matter of time until this sector really becomes one of the hottest sectors in the world if it's not already one of the hottest sectors in the world. So let's just talk a little bit about how psychedelics are helping athletes. So this hockey player, Carcillo, as an enforcer, his role was to protect star players at any cost and that often meant acting as a human shield. Carcillo was forced to retire early from the NHL after repeated concussions, too many shots to the head and resulting traumatic brain injury began to destroy his quality of life. Carcillo is not the only NHL player who has struggled with mental health issues as a result of playing high impact sports. Fellow NHL players such as Wade Bilak who played for the Toronto Maple Leafs, Rick Rippin and former teammate Steve Montador all died unexpectedly after suffering from mental health issues as a result of repeated head trauma. Since his retirement, Carcillo has become the founder and CEO of Wasana Health, a company focusing on developing treatment for traumatic brain injury TBI to be to help others experience the potential benefits of Silo Saibon. While professional athletes from hockey players to boxers, football players and baseball players have been turning to psychedelics to treat complex mental health issues, the use of psychedelics in the medical field is nothing new. HB says of Rich TV traded on the NASDAQ that we traded $1,000 a share. Rich is the real deal. Hey, thank you HB, I appreciate you. Good morning Seth, hope you're having a great day. What do you guys think of new meat wellness? If you like this video, smash the like button, comment down below, share the video everywhere and subscribe. With decades of academic research providing supporting evidence of the beneficial therapeutic benefits of psychedelics for patients diagnosed with conditions such as traumatic brain injury, depression, anxiety, PTSD, addiction and a host of other mental health issues, psychedelic medicines are grabbing major funding, scientific support and interest from prolific investors. And we get the opportunity to get in first and we get the opportunity to get in early. And in my opinion, we are very early to the psychedelic revolution. I was the first one ever to bring you guys mind medicine. I was one of the first ones ever to bring a new meat wellness. And if you're part of my club, you know that I've got a whole slew of other psychedelic stocks that I'm bringing to our club and to our community and that I'm bringing to the world here in Rich TV Live almost daily because this is one of the hottest, fastest growing sectors in the world. And it's just in the infancy stages. A leading psychedelic company addressing the universal desire to heal and be well. Numinous Wellness Inc. is a mental health and wellness company creating an ecosystem of solutions to research, develop and deliver safe evidence-based accessible psychedelic assisted psychotherapy. Numinous Wellness went public in 2020 after raising an initial $10 million with institutional support from KanaCorp Genuity and 8 Capital. After listing on the TSX Venture Exchange, Numinous Wellness ended 2020 with an oversubscribed financing raising an additional $17 million. So this is a company that's just getting started, has already exploded and has already been able to raise $27 million. Why would $27 million be pouring into a company if they did not have a future? I believe the future is extremely bright for the psychedelic sector and I believe that the future is very bright for Numinous Wellness. Numinous Wellness has a multi-pronged business strategy which includes Numinous Bioscience, Numinous R&D, and Numinous Clinics. Together, these create a dynamic synergy as the combination of business segments positions the company at the forefront of psychedelics for healing and wellness. Numinous Wellness is also the first public company with a Health Canada License Lab for psychedelic substance research. Not only does their license allow for research, but allows Numinous Wellness to produce and extract psilocybin from mushrooms from which they were also recognized as the first public company to complete a legal harvest. Numinous Wellness Inc. operates four clinics in Canada with a focused on delivering personalized therapy from these clinics both virtually and in person. Not only do they operate physical clinics, but Numinous Wellness has a 7,000 square feet laboratory with top-of-the-line equipment to deliver applied research, IP development, and R&D partnerships. Numinous Wellness has a strong management team with technical, scientific, and capital markets experience to execute on all business plans. I don't think that you raised 27 million dollars unless you know what you're doing. I don't think you do that by luck. Moreover, the company has been recognized and validated by the investment community after becoming the Horizon Psychedelic Stock Index ETF, PSYK, top-weighted holding at 9.89% at the date of the ETF launch, January 27, 2021. So the psychedelics ETF decided that they were going to position themselves with the most in Numinous Wellness. If that doesn't tell you where they stand with all the psychedelic stocks, I don't know what does. Why would the ETF position themselves so greatly in Numinous Wellness? Their biggest position in Numinous Wellness if they didn't see huge potential, huge upside for Numinous Wellness, and I agree with them. Six reasons why Numinous Wellness is the psychedelic stock to watch in 2021. Number one, favorable regulatory landscape Canadian and US government continues to make changes to laws and regulations, decriminalizing the use of psychedelics in Denver, Oakland, Santa Cruz, Somerville, and Vancouver, Canada, where I happen to be. And now the entire state of Oregon has now only decriminalized psilocybin but legalized it for therapeutic use. And now the entire state of Oregon has not only decriminalized psilocybin but legalized it for therapeutic use. Healthcare is failing with limited options. 971 million people worldwide are suffering from a mental disorder. That number is just staggering. In Canada, one out of two Canadians are affected by mental health, issues by the age of 41 out of two. That is concerning. Massive market opportunity psychedelics are an entirely new category of medication, which has a $100 billion total addressable market for mental health, licensing advantage for psychedelic research. Numinous is the first public company in Canada to receive a license to produce and extract psilocybin from mushrooms. Company also possesses a dealer license from Health Canada to import, export, possess, test, and distribute molly, psilocybin, psilocin, n, n, demyth, thrypotene, and mescaline. They have a strong leadership and R&D team. Numinous is led by scientific, medical, and business leaders with expertise in international healthcare research, policy reform, regulatory affairs, capital markets, technology, and government relations. Huge, huge fan of Numinous wellness and why not? Why not? They are a huge success story already, and I believe that this is a story that is just getting started. Absolutely just getting started, and the reality is we're just talking about them today for only the second time. So the reality is not everybody knows about these guys yet. Numinous is led by scientific, medical, business leaders with expertise in international healthcare research, policy reform, regulatory affairs, capital markets, technology, and government relations. They're also the first public company to complete a legal harvest of psilocybin mushrooms. In December, Numinous completed the first legal extraction of psilocybin mushrooms in Canada by public company for R&D purposes. Numinous wellness was the first publicly traded company in Canada to be granted a license by Health Canada to research the standardization of psilocybin for mushrooms. The license is a critical differentiator between the company and its peers as it allows Numinous wellness to develop the license and license its own exclusive IP for further product development in partnership with leading research organizations. So given its current market capitalization, strong scientific background, and laboratory to cultivate some research, it's hard to believe that Numies, one of the cheapest stocks in the sector, will compare to its peers. For instance, Compass Pathways, which received FDA breakthrough therapy designation for its psilocybin therapy program in treatment resistant depression in 2018, is currently valued at almost $2 billion. MindMed, which is currently conducting phase 2A clinical trials, evaluating the efficacy of treating anxiety with acid, is now worth about US $1.3 billion, and its share price just grew 10x in the last six months, and I brought it to you first. This shows how much money investors are willing to pump into promising psychedelic companies. Numies holds just as much potential as its two peers, if not more, when you consider the long term. That's a big statement. That is a huge statement. Hey, and for Drew, good morning. What do you think of Numie Wellness? For starters, Numie Wellness Inc., Numie in Canada, LKYSF in America, is already generating some revenue from its first public company to complete a legal harvest of psilocybin mushrooms, as well as the first to receive health Canada license to produce and extract psilocybin from mushrooms. Putting all this together, Numie has clear advantages over its peers. Even if Numie doesn't get valued at the same multiple as these companies, it's clear that there is significant upside potential to the stock, especially considering that it plans on developing its own psilocybin products later on this year. Institutional money sees the opportunity in Numie Wellness. As it was listed as the largest-weighting 9.89% for its first ever psychedelic ETF, and I told you guys about this, the Horizon's Psychedelic Index ETF, PSYK, which launched on January 27th. You can see where they compare to their peers. The best part here about mind medicine is they have no revenue. And despite the fact that they have no revenue, they're already at a 1.2 billion market cap and they're up a thousand percent, more than a thousand percent. So you can see where Numinous Wellness compares with their 200 million market cap, comparing them to mind medicine, a 1.2 million market cap, Compass Pathways, a 1.7 million market cap, Midasine Innovations, which I brought to you guys earlier this week, 55 million market cap, and Cybin Inc, CYBN, a 184 million market cap. You can see the trend here for Numie, and I showed you guys with the chart earlier, Numinous shares have been on an upward trend with no signs of slowing down. On October 1st, 2020, shares were trading at just 49 cents Canadian, and by February 19, 2021, they had climbed back to $1.74, translating to almost 600% gain in four months. If the stock manages to break past the current resistance of $1.74, there's a high likelihood it could go and surge even higher. And I would say that the $2 range is the next big, big catalyst, the next big point of resistance that they're going to be looking to break. So Canada is paving the way for the global adoption of psychedelic medicines, creating an exciting investment opportunity. So I'm not going to go through all of this, but huge fan of Numie Wellness, and I believe that they are a play that everybody needs to put on their watch list, and everybody needs to put on their radar. Love to know what you guys think about Numie Wellness. I think that they're undervalued, underappreciated, underexposed. They've already raised a lot of money. They've got a strong team. Let's talk about their leadership team. So the leadership team is the perfect blend of acclaimed scientists, mental health experts, and successful entrepreneurs. So Peyton, Nike Vist, co-founder and chief executive officer and executive 15 years plus in Canada, US capital markets, including raises for early hemp companies, raised 100 million plus for public and private companies across North America, former vice president and head of sales of one of Canada's largest independent brokerages, Stacy Wallen, co-founder and chief strategy officer, former founder, CEO of biotech, workplace safety and wearable startup with Fortune 100 clients, tech growth and scale and policy change experience as co-founder of the Canadian accelerator incubator network and former director of venture programs at BC Tech Association. So you can see some of the people that are working. Dr. Evan Wood, who's the chief medical officer, Michael Tan, who's the chief operations officer, John Fong, who's a CPA and chief financial officer. So strong team and once again, eight reasons why investors should keep numinous wellness on their radar. Number one, prolific investors entering the market, Peter Thiel, the founder of PayPal and Palantir has been investing in psychedelics along with Kevin O'Leary and Bruce Linton, who are heavily involved in biomedicine on the brink of regulatory change. Like hemp in its infancy, psychedelics are gaining momentum as the regulatory policies begin to adapt to the evolving landscape. Multi-faceted approach to the industry, companies focused on three different segments of the market, creating a diversified and synergistic approach to success. Health Canada License Lab, first public company with a license to cultivate and harvest psilocybin for research and development and intellectual property, war chest of cash, approximately $30 million of cash in the bank to execute on its business milestones. Not bad for a company just getting started. $100 billion market opportunity, low market capitalization relative to the total addressable market with a company being valued at only $200 million as of February 25th, 2021. Season management and R&D team, medical team with over 500 plus peer review publications and management team with strong capital markets IQ, which is why they're able to raise capital and why the stock's done well. You need to have a team that knows what they're doing. Companies don't just do well, they do well because they have the right team leading the ship. Top ETF holding Horizon Psychedelic Stock Index ETF, PSYK, the first psychedelic ETF listed Numinous Wellness, Inc., as its largest holding at 9.89% on the date of launch January 27th, 2021. Now remember, Rich TV Live is strictly for education and entertainment purposes. Always do your due diligence, always do your research before you invest in anything that we talk about here in Rich TV Live. I'd love to know what you guys think. I do spend a lot of time researching companies. I do spend a lot of time learning about companies and I do spend a lot of time talking to investors about companies. This is a company I think everyone should have on their watch list. Everyone should have on the radar. Everyone should be aware of. They are potentially going to be one of the biggest players in the psychedelic space and they are still early. As you can see, at $1.21 in America and despite the fact that they've gone up huge and at $1.51 in Canada, still in my opinion, very undervalued, underappreciated, underexposed, with incredible odds to the upside. Love to know what you think. Please let me know. Comment on the video. Share the video everywhere and subscribe if you're alive. This is Rich from Rich TV Live bringing you Numinous Wellness, a company that I think has a chance to be a global leader in psychedelics. Thank you for watching. Let me know what you guys think. Comment down below. Comment on the video. What do you think about Numinous Wellness? And they just had the big news, Optomy Health and Numinous Wellness to conduct psychedelic lab research and development. News is circulating and I'm going to continue to do some more research. Once again, LKYSF in America on the OTC Pink Exchange and NUMI on the Toronto Stock Venture Exchange. If you're not winning, you're not watching. We're bringing the winners and we're bringing them to you first. We brought you NUMI Wellness first. It's $0.78, currently $1.50 and I think that the upside and the future looks bright. Have yourselves a great day. This is Rich from Rich TV Live and I'm out. Peace.